Supriya Roy
Madhav Chanchani
Supriya Roy
Madhav Chanchani
In a crowded market comprising conglomerates, MNCs and cash-rich startups, 1mg has spent the last year improving its supply chain and expanding. The Tata Digital-owned company is now raising more capital, but will it be enough to take on the heavily funded Pharmeasy and Reliance-backed Netmeds?
July 27, 2022
11 MINS READAbout two years ago, just when the first wave of the Covid-19 pandemic sparked a spike in demand for deliveries by online pharmacy players, 1mg Technologies hit the market to raise a new round of funding.
When it started out, 1mg was not meant to be an online pharma company. At least, that was not founder Prashant Tandon’s and then co-founder Sameer Maheshwari’s original business idea back in 2011. The startup was an offshoot of e-commerce platform Healthkart, best known for selling supplements. It was known as Healthkartplus – an online marketplace for health devices, personal care, fitness and nutrition supplements, sports nutrition, eye-care and so on, having tie-ups with top distributors and retailers in different cities.
But in 2015, Tandon, a McKinsey consultant with an MBA from Stanford, decided to demerge the business.
Fintech
Premium Reads
By Dr Srinath Sridharan
The Crux
the-crux
By Pranav Balakrishnan
Aviation
Premium Reads
By Raghav Mahobe
Digital payments
Premium Reads
By Nikhil Patwardhan
E-commerce
the-crux
By Pranav Balakrishnan
8 Min Read
By Dr Srinath Sridharan
10 Min Read
By Raghav Mahobe
11 Min Read
By Nikhil Patwardhan
4 Min Read
By Sohini Mitter
13 Min Read
By Pranav Balakrishnan
12 Min Read
By Nikhil Patwardhan